News2020-06-06T12:18:49-04:00

Advaita Bioinformatics News

A leader in the interpretation of high-throughput biomedical data.

Cloudbleed and Advaita

February 17, 2017|iBioGuide, iPathwayGuide, iVariantGuide|

On February 17, 2017, we found out about Cloudbleed, a major leak of user data affecting several sites and services that use infrastructure provided by Cloudflare. As part of Advaita’s commitment to offering a HIPAA compliant secure informatics platform, we [...]

Advaita and Riken-Genesis Team up in Japan

April 1, 2015|In the Press, Updates|

Advaita Bioinformatics (Advaita) announced today that it has entered into an exclusive partnership with Riken Genesis Co. Ltd., (Riken-Genesis) for the promotion and sale of Advaita’s flagship product, iPathwayGuide in Japan. Under the agreement, iPathwayGuide will be a featured informatics [...]

SCIEX Announces OneOmics Collaborators

March 16, 2015|In the Press, Updates|

SCIEX a global leader in life science analytical technologies today announced collaborators in the OneOmics™ project an exclusive partnership between Illumina and SCIEX that integrates SWATH™ Acquisition based next-generation proteomics (NGP) and next-generation sequencing (NGS) data on the BaseSpace® cloud [...]

Advaita lands nearly $2M in SBIR funding

May 15, 2014|In the Press, Updates|

Advaita scored nearly $2 million in seed capital this month after it landed the second phase of an SBIR grant to develop its bioinformatics software. "It will allow us to continue development of our software tools and our products for [...]

Advaita Secures $1.76M Phase II Award

April 18, 2014|In the Press, Updates|

Today, Advaita Bioinformatics received a Notice of Award from the National Institutes of Health’s (NIH) National Institute of General Medical Sciences (NIGMS) for a Phase II Small Business Investigational Research (SBIR) grant worth $1.76M over three years. Advaita is a [...]

Load More Posts
Advaita Bioinformatics

About Advaita Bioinformatics

Advaita Bioinformatics is a leader in the interpretation of high-throughput biomedical data including variant interpretation, pathway analysis, disease subtype discovery and integration of multiple data types. Currently, 9 of the top 10 pharma companies rely on Advaita’s state-of-the-art algorithms to solve complex problems. Advaita was founded by Sorin Draghici, a professor at Wayne State University, and provides a suite of advanced analysis software to more that 13,000 registered users worldwide: iPathwayGuide, for functional interpretation of genes and proteins; iVariantGuide, for genetic variant analysis; and iBioGuide, a search engine revealing connections between genes, pathways, SNPs, drugs, and more. Sorin Draghici is also the CEO of Advaita Bioinformatics.

Subscribe to Our Newsletter
SUBSCRIBE TO ADVAITA UPDATES AND NEWSLETTERS